OSUR
OraSure Technologies, Inc.NASDAQHealthcare$3.08+0.98%ClosedMarket Cap: $212.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.65
P/S
1.85
EV/EBITDA
-3.61
DCF Value
$-3.63
FCF Yield
-25.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
38.2%
Operating Margin
-59.2%
Net Margin
-59.8%
ROE
-18.6%
ROA
-17.1%
ROIC
-18.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $26.8M | 41.0% | $-16.9M | $-19.3M | $-0.27 | — |
| FY 2025 | $115.0M | 41.9% | $-68.1M | $-68.7M | $-0.94 | — |
| Q3 2025 | $27.1M | 38.3% | $-15.7M | $-13.7M | $-0.19 | — |
| Q2 2025 | $31.2M | 37.4% | $-17.3M | $-19.7M | $-0.26 | — |
| Q1 2025 | $29.9M | 36.4% | $-18.3M | $-16.0M | $-0.21 | — |
| Q4 2024 | $37.4M | 36.9% | $-11.6M | $-10.8M | $-0.14 | — |
| FY 2024 | $185.8M | 41.0% | $-20.6M | $-19.5M | $-0.26 | — |
| Q3 2024 | $39.9M | 42.8% | $-5.6M | $-4.5M | $-0.06 | — |
| Q2 2024 | $54.3M | 47.1% | $-34.0K | $-615.0K | $-0.01 | — |
| Q1 2024 | $54.1M | 44.9% | $-3.4M | $-3.6M | $-0.05 | — |
| Q4 2023 | $75.9M | 47.0% | $7.7M | $20.1M | $0.27 | — |
| FY 2023 | $405.5M | 44.2% | $54.1M | $53.7M | $0.72 | — |